UBS lowered the firm’s price target on Oracle (ORCL) to $200 from $210 and keeps a Buy rating on the shares. Another revenue miss is a setback, but is trumped by the fiscal 2027 guidance for 20% growth, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
- Oracle price target lowered to $150 from $175 at Stifel
- Oracle price target lowered to $170 from $175 at Morgan Stanley
- BofA cuts Oracle target, says 2026 targets ‘likely a stretch’
- Oracle price target lowered to $185 from $200 at Evercore ISI
- Oracle price target lowered to $202 from $212 at Barclays